Search

everythinglearnresearchcommunity

for

Search:↓

Mice are useful for researching human hair loss and testing treatments, despite some differences between species.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

Early diagnosis and aggressive treatment are crucial for better outcomes in lymphomatoid granulomatosis.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

A dermoscope helps accurately tell apart Pityrosporum folliculitis and Acne vulgaris.

People with alopecia have a higher risk of thyroid cancer.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Certain skin drugs and topical agents, including some natural extracts and fragrances, can cause allergic reactions. Some hair dyes and extensions, as well as minoxidil, a hair growth treatment, can also cause allergies. Botulinum toxin A can effectively reduce sweat but may have temporary side effects.

Hydrogel scaffolds can help wounds heal better and grow hair.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

Oral cyclosporin doesn't stop hair loss.

Hairless protein is key for hair growth, cell differences cause gene expression variation, and the N-end rule pathway senses nitric oxide for protein breakdown.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

Protein analysis shows aging changes in scalp cell types from women.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Low testosterone levels may lead to more severe COVID-19 outcomes.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Anabolic steroid users may face higher risk of severe COVID-19.

Hair loss doesn't affect COVID-19 severity.